AKT1 and lung adenocarcinoma: It has been reported that dioscin, a therapeutic agent for lung adenocarcinoma, can suppress the proliferation, invasion and EMT of lung cells via the inactivation of AKT/mTOR/GSK3β signaling pathway [32].